Syno Capital
Overview
We are a global investment firm that promotes collaborations among China, United States, Europe and the rest of the world. We invest in innovative and disruptive emerging life science, biotech and healthcare companies and help grow them into an international industry leader.
Investment Focus
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
- Potential for significant market impact
- Alignment with Syno Capital's investment philosophy
Portfolio Companies
Reach Syno Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Syno Capital
What sectors does Syno Capital invest in?
Syno Capital invests in Healthcare, Life Sciences, Healthcare Services, Digital Health, Pharmaceuticals and Medical Devices, and is based in New York, New York, United States. Syno Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does Syno Capital invest at?
Syno Capital backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Syno Capital invest in?
Syno Capital invests across United States, Hong Kong, China and Shanghai.
What companies has Syno Capital invested in?
Syno Capital's portfolio includes Applied Therapeutics, Abalo Bio, Accro Bioscience, 7 Hills Pharma Inc., AAVnerGene Inc. and Back to top.
How do I contact Syno Capital?
Syno Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
